Angiodroid

📍 San Lazzaro di Savena, Italy🗓 Founded 2013👥 38 employees💰 Last funded Mar 2023
Angiodroid SpA is an Italian innovative Company that projects and trades solutions for the medical market. Angiodroid® The CO2 Injector is our main product. It is a Carbon Dioxide (CO2) Injector for Interventional Radiology procedures and represents the perfect solution for the treatment of patients with: • Contrast Induced Nephropathy (CIN) risk • Diabetic Disease • Renal Failure • Intolerance to Iodinated contrast media The use of CO2 in Peripheral Angiography has been common practice for many decades. To date, however, it has not the proper success due to the lack of advanced technology which could support operators during the procedures. Until now, the market solution was the use of manual injection kits (that means no procedural repeatability, no control of injection pressure and air contamination risk). Angiodroid® The CO2 Injector, whose main fields of application are Interventional Radiology & Vascular Surgery, is the perfect solution to all these problems and is the only injector: • 100 % automatic • 100 % safe • 100 % digital • 100 % user friendly More info at www.angiodroid.com
3
Total investors
2
Early stage
0
Mid stage
1
Late stage
2013
Founded
Investor geography1 country
Italy
3
Investor activity2015–2023 · investors recorded per year
2015220231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Angiodroid?
Angiodroid has 3 investors on record on gritt.io, including 2 early-stage backers and 1 late-stage investors.
When did Angiodroid last raise funding?
The most recent investment in Angiodroid recorded on gritt.io was in March 2023.
When was Angiodroid founded?
Angiodroid was founded in 2013.
What industry is Angiodroid in?
Angiodroid operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Angiodroid based?
Angiodroid is headquartered in San Lazzaro di Savena, Italy.